Browsing: Ipsen Withdraws Oncology Drug
Ipsen Withdraws Oncology Drug Tazverik Following Disappointing Results from Confirmatory Clinical Trials
By Global Desk
The pharmaceutical landscape for specialized cancer treatments shifted significantly today as Ipsen announced the voluntary withdrawal of Tazverik from the…
Investing
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.
© 2026 New York Frontier. All Rights Reserved. Made in United States of America.